Genomic analysis confirmed the typical ccRCC mutation profile including VHL, PBRM1, and SETD2 mutations, and revealed PBRM1 as a uniquely mutated gene in the CD3high subgroup. This evidence concerns the gene SETD2 and nonpapillary renal cell carcinoma.